Nebula Research & Development »

Soleno Therapeutics shares owned by Nebula Research & Development

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Nebula Research & Development from 13F filings

Historical chart of Nebula Research & Development investment in Soleno Therapeutics

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.001220.033k220.0335k220.034k220.0345k220.035k43574,357.543584,358.54359
Value ($)Share countHistorical SLNO position of Nebula Research & … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Nebula Research & Development consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Nebula Research & Development

Quarter filed Position value Share count Share price at filing
2024-09-30 $220k 4.4k 50.49

More positions owned by Nebula Research & Development

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Autodesk (ADSK)
Allstate Corporation (ALL)
TJX Companies (TJX)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Tapestry (TPR)
Atlassian Corporation Cl A (TEAM)
Regeneron Pharmaceuticals (REGN)
Stride (LRN)
Cintas Corporation (CTAS)
BioMarin Pharmaceutical (BMRN)
Epam Systems (EPAM)

View all positions for Nebula Research & Development

Top funds holding Soleno Therapeutics

Vivo Capital
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Susquehanna International
venBio Select Advisor
BlackRock
Vanguard Group
T. Rowe Price Associates
Perceptive Advisors
Carlyle
State Street Corporation
Citadel Advisors
Commodore Capital
Caption Management

View all funds holding Soleno Therapeutics